Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
Protocol summary
Study aims to investigate and compare the effects of Berberis aristata extract and deep tissue foot massage with jasmine oil on individuals with diabetes mellitus. Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels
This study aims to find out synergistic effect Berberis aristata and metformin in lowering blood glucose level in diabetic patients.Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels
StudyThis study aims to investigate and compare the effects offind out synergistic effect Berberis aristata extract and deep tissue foot massage with jasmine oil on individuals with diabetes mellitus. Diabetesmetformin in lowering blood glucose level in diabetic patients.Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels
Study was conducted at Muhammad Institute of Medical and Allied Sciences Multan after approval from Institutional ethical committee.
Study will be conducted at Muhammad Institute of Medical and Allied Sciences Multan after approval from Institutional ethical committee.
Study waswill be conducted at Muhammad Institute of Medical and Allied Sciences Multan after approval from Institutional ethical committee.
Patients will be recruited by using the lottery method. Informed consent will be taken from patient. Two groups will be treatment groups. The first treatment group-A will be treated with therapeutic deep tissue massage with jasmine oil deep tissue foot massage for three weeks, The time duration for deep tissue massage will be 30 minutes per day Massage will be applied for 15 minutes on each foot. and the second group-B will be treated with berberis aristate 1g capsule two times in a day at lunch time and at dinner time. After 6 weeks we will compare pre and post glucose level and lipid levelin diabetics patients. We will measure objective data glucose level and lipid level.
Patients will be recruited by using the lottery method into three groups. Informed consent will be taken from patient. Group A will be treated with Berberis aristata (550 mg twice a day) orally. Group B will be given metformin orally (500 mg). Group C will be given both Berberis aristata and metformin (550/250 mg once). The treatment regimen will be 6 weeks. Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation of all the patients with diabetes type-2 at baseline and after 6 weeks.
Patients will be recruited by using the lottery method into three groups. Informed consent will be taken from patient. Two groups will be treatment groups. The first treatment group-Group A will be treated with therapeutic deep tissue massage with jasmine oil deep tissue foot massage for three weeks, The time duration for deep tissue massage will be 30 minutes perBerberis aristata (550 mg twice a day Massage will be applied for 15 minutes on each foot) orally. and the second group-Group B will be treated with berberis aristate 1g capsule two times in a day at lunch timegiven metformin orally (500 mg). Group C will be given both Berberis aristata and at dinner timemetformin (550/250 mg once). AfterThe treatment regimen will be 6 weeks we will compare pre. Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and post glucose leveloxygen saturation of all the patients with diabetes type-2 at baseline and lipid levelin diabetics patientsafter 6 weeks. We will measure objective data glucose level and lipid level.
Cardiometabolic and cardiorespiratory parameters including blood glucose level and cholesterol level. Mean of arterial pressure (MAP), heart rate, respiratory rate, oxygen saturation
Cardiometabolic and cardiorespiratory parameters including Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation
Cardiometabolic and cardiorespiratory parameters including Blood glucose, blood glucose level andpressure, blood cholesterol level. Mean of arterial pressure (MAP), respiration rate, heart rate, respiratory rateketone bodies, HbA1c, DDS score and oxygen saturation
General information
396
295
396295
empty
Slight modifications
Slight modifications
Berberis Aristata and deep tissue foot massage with jasmine oil in diabetic patient
Berberis Aristata and Metformin in Diabetic Patients
Berberis Aristata and deep tissue foot massage with jasmine oilMetformin in diabetic patientDiabetic Patients
Comparative effect of Berberis Aristata and deep tissue foot massage with jasmine oil in diabetic patient
Synergistic Effect of Berberis Aristata and Metformin in Diabetic Patients-A Randomized Controlled Trial
Comparative effectSynergistic Effect of Berberis Aristata and deep tissue foot massage with jasmine oilMetformin in diabetic patientDiabetic Patients-A Randomized Controlled Trial
Simple randomization. We used sealed envelops for lotterty method and randomization of participants was done. Randomization of participants in groups by lottery method Simple randomization.
We used sealed envelops for lotterty method and randomization of participants was done. Randomization of participants in groups by lottery method Simple randomization.
Simple randomization. We used sealed envelops for lotterty method and randomization of participants was done. Randomization of participants in groups by lottery method Simple randomization.
Primary outcomes
#1
Increase in Blood circulation and insulin secretion in diabetic patients
Glucose level in diabetic patients
Increase in Blood circulation and insulin secretionGlucose level in diabetic patients
#2
empty
HbA1C
HbA1C
empty
6 weeks
6 weeks
empty
Blood sampling
Blood sampling
Intervention groups
#1
Treatment - Other
Treatment - Drugs
treatment-otherdrugs
Intervention group: Group-A will be treated with therapeutic deep tissue massage with jasmine oil deep tissue foot massage for three weeks and the time duration for deep tissue massage will be 30 minutes per day. Massage will be applied for 15 minutes on each foot. After 6 weeks we will compare pre and post glucose level and lipid level in diabetics patients.
Intervention group: Group A will be treated with Berberis aristata (550 mg twice a day) orally. The treatment regimen will be 6 weeks. Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation of all the patients with diabetes type-2 at baseline and after 6 weeks.
Intervention group: Group-A will be treated with therapeutic deep tissue massage with jasmine oil deep tissue foot massage for three weeks and the time duration for deep tissue massageBerberis aristata (550 mg twice a day) orally. The treatment regimen will be 30 minutes per day6 weeks. Massage will be applied for 15 minutes on each foot. AfterBlood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation of all the patients with diabetes type-2 at baseline and after 6 weeks we will compare pre and post glucose level and lipid level in diabetics patients.
#2
Intervention group: Group-B will be treated with Berberis Aristate 1g capsule two times in a day at lunch time and at dinner time. After 6 weeks we will compare pre and post glucose level and lipid level in diabetics patients.
Intervention group: Group B will be given metformin orally (500 mg). The treatment regimen will be 6 weeks. Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation of all the patients with diabetes type-2 at baseline and after 6 weeks
Intervention group: Group-B will be treated with Berberis Aristate 1g capsule two times in a day at lunch time and at dinner timegiven metformin orally (500 mg). AfterThe treatment regimen will be 6 weeks we will compare pre. Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and post glucose leveloxygen saturation of all the patients with diabetes type-2 at baseline and lipid level in diabetics patients.after 6 weeks
#3
empty
Treatment - Drugs
treatment-drugs
empty
Intervention group: Group C will be given both Berberis aristata and metformin (550/250 mg once). The treatment regimen will be 6 weeks. Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation of all the patients with diabetes type-2 at baseline and after 6 weeks.
Intervention group: Group C will be given both Berberis aristata and metformin (550/250 mg once). The treatment regimen will be 6 weeks. Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation of all the patients with diabetes type-2 at baseline and after 6 weeks.
empty
گروه مداخله:
گروه مداخله:
Person responsible for general inquiries
contact.organization_id:
Name of organization / entity - English: Muhammad Institute of Medical and Allied Sciences, Multan
Name of organization / entity - Persian:
Full name of responsible person - English: Maliha Khalid Khan
Full name of responsible person - Persian:
Position - English: Demonstrator
Position - Persian:
Latest degree: med_doctor
Area of specialty/work: 68
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Hbl street sabsazar metro station
Street address - Persian:
City - English: Multan
City - Persian:
Province: Punjab
Province - English: Punjab
Province - Persian:
contact.provinces_available:
Country: Pakistan
Postal code: 66000
Phone: 031268267130
Mobile: 031268267130
Fax:
Email: malihatareen1997@gmail.com
Web page address:
contact.organization_id:
Name of organization / entity - English: Muhammad Institute of Medical and Allied Sciences, Multan
Name of organization / entity - Persian:
Full name of responsible person - English: Maliha Khalid Khan
Full name of responsible person - Persian:
Position - English: Demonstrator
Position - Persian:
Latest degree: med_doctor
Area of specialty/work: 68
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Hbl street sabsazar metro station
Street address - Persian:
City - English: Multan
City - Persian:
Province: Punjab
Province - English: Punjab
Province - Persian:
contact.provinces_available:
Country: Pakistan
Postal code: 66000
Phone: +92 312 6827130
Mobile: +92 312 6827130
Fax:
Email: malihatareen1997@gmail.com
Web page address:
contact.organization_id: Name of organization / entity - English: Muhammad Institute of Medical and Allied Sciences, Multan Name of organization / entity - Persian: Full name of responsible person - English: Maliha Khalid Khan Full name of responsible person - Persian: Position - English: Demonstrator Position - Persian: Latest degree: med_doctor Area of specialty/work: 68 Area of specialty/work title - English: Area of specialty/work title - Persian: Street address - English: Hbl street sabsazar metro station Street address - Persian: City - English: Multan City - Persian: Province: Punjab Province - English: Punjab Province - Persian: contact.provinces_available: Country: Pakistan Postal code: 66000 Phone: 031268267130+92 312 6827130 Mobile: 031268267130+92 312 6827130 Fax: Email: malihatareen1997@gmail.com Web page address:
Protocol summary
Study aim
This study aims to find out synergistic effect Berberis aristata and metformin in lowering blood glucose level in diabetic patients.Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels
Design
Lottery method, community bases,parallel group, double blinded, randomized control trial.
Settings and conduct
Study will be conducted at Muhammad Institute of Medical and Allied Sciences Multan after approval from Institutional ethical committee.
Participants/Inclusion and exclusion criteria
Inclusion criteria:
Age group of 25-70 years Both Genders (Male, Female) Hypertensive patients Married and unmarried Educated and uneducated Diabetic patients
Exclusion criteria:
Any type of mental disability Lactating females Having any type of physical disability History of chest pain, bronchitis, asthma, angina, MI Chronic illness related to cardiorespiratory ailments Any type of major surgery• Pregnant females
Intervention groups
Patients will be recruited by using the lottery method into three groups. Informed consent will be taken from patient. Group A will be treated with Berberis aristata (550 mg twice a day) orally. Group B will be given metformin orally (500 mg). Group C will be given both Berberis aristata and metformin (550/250 mg once). The treatment regimen will be 6 weeks. Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation of all the patients with diabetes type-2 at baseline and after 6 weeks.
Main outcome variables
Cardiometabolic and cardiorespiratory parameters including Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation
General information
Reason for update
Slight modifications
Acronym
IRCT registration information
IRCT registration number:IRCT20230202057310N3
Registration date:2023-09-07, 1402/06/16
Registration timing:prospective
Last update:2024-08-20, 1403/05/30
Update count:1
Registration date
2023-09-07, 1402/06/16
Registrant information
Name
Imran Ahmad Khan
Name of organization / entity
Muhammad Nawaz Shareef University of Agriculture, Multan
Country
Pakistan
Phone
+92 333 6120602
Email address
imran.ahmad@mnsuam.edu.pk
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-09-10, 1402/06/19
Expected recruitment end date
2024-01-06, 1402/10/16
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Synergistic Effect of Berberis Aristata and Metformin in Diabetic Patients-A Randomized Controlled Trial
Public title
Berberis Aristata and Metformin in Diabetic Patients
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age group of 25-70 years
Both Genders (Male, Female)
Married and unmarried
Educated and uneducated
Diabetic patients
Exclusion criteria:
Any type of mental disability
Lactating females
Having any type of physical disability
History of chest pain
bronchitis
Any type of major surgery
Pregnant females
Asthma
Angina
MI Chronic illness related to cardiorespiratory ailments
Age
From 25 years old to 70 years old
Gender
Both
Phase
1-2
Groups that have been masked
Investigator
Data analyser
Sample size
Target sample size:
295
Randomization (investigator's opinion)
Randomized
Randomization description
We used sealed envelops for lotterty method and randomization of participants was done. Randomization of participants in groups by lottery method Simple randomization.
Blinding (investigator's opinion)
Double blinded
Blinding description
Double blinded study was done by keeping blind i-e the physiotherapist as Investigator and data analyser to avoid biasness and ro get the authentic results
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Muhammad Institute of Medical and Allied Sciences Multan
Street address
HBL Street, Bosan Road Multan.
City
Multan
Postal code
66000
Approval date
2023-08-10, 1402/05/19
Ethics committee reference number
MIMAS/08/27/IAK.DURRANI
Health conditions studied
1
Description of health condition studied
Diabetes Mellitus
ICD-10 code
E08
ICD-10 code description
Diabetes mellitus due to underlying condition
Primary outcomes
1
Description
Glucose level in diabetic patients
Timepoint
6 weeks
Method of measurement
Blood glucose level by glucometer
2
Description
Cholesterol level
Timepoint
6 weeks
Method of measurement
Lipid profile meter
3
Description
HbA1C
Timepoint
6 weeks
Method of measurement
Blood sampling
Secondary outcomes
1
Description
Cardiorespiratory parameters
Timepoint
6 weeks
Method of measurement
Pulse oximeter, Manometer for blood pressure monitoring
Intervention groups
1
Description
Intervention group: Group A will be treated with Berberis aristata (550 mg twice a day) orally. The treatment regimen will be 6 weeks. Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation of all the patients with diabetes type-2 at baseline and after 6 weeks.
Category
Treatment - Drugs
2
Description
Intervention group: Group B will be given metformin orally (500 mg). The treatment regimen will be 6 weeks. Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation of all the patients with diabetes type-2 at baseline and after 6 weeks
Category
Treatment - Drugs
3
Description
Intervention group: Group C will be given both Berberis aristata and metformin (550/250 mg once). The treatment regimen will be 6 weeks. Blood glucose, blood pressure, blood cholesterol, respiration rate, heart rate, ketone bodies, HbA1c, DDS score and oxygen saturation of all the patients with diabetes type-2 at baseline and after 6 weeks.
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Muhammad Institute of Medical and Allied Sciences Multan
Full name of responsible person
Maliha Khalid Khan
Street address
Hbl street sabsazar metro station
City
Multan
Postal code
66000
Phone
+92 312 6827130
Email
malihatareen1997@gmail.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Muhammad Institute of Medical and Allied Sciences, Multan
Full name of responsible person
Imran Ahmad Khan
Street address
Hbl street sabsazar metro station
City
Multan
Postal code
66000
Phone
+92 333 6120602
Email
imranahmadkhandurrani@gmail.com
Grant name
Student fund
Grant code / Reference number
27082023
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Muhammad Institute of Medical and Allied Sciences, Multan
Proportion provided by this source
70
Public or private sector
Private
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Muhammad Institute of Medical and Allied Sciences, Multan
Full name of responsible person
Maliha Khalid Khan
Position
Demonstrator
Latest degree
Medical doctor
Other areas of specialty/work
Physiotherapy
Street address
Hbl street sabsazar metro station
City
Multan
Province
Punjab
Postal code
66000
Phone
+92 312 6827130
Email
malihatareen1997@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Department of Pharmacology and Physiology, MNSUA Multan.
Full name of responsible person
Imran Ahmad Khan
Position
Lecturer
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
Old Shuja Bad Road Multan
City
Multan
Province
Punjab
Postal code
66000
Phone
+92 333 6120602
Email
imran.ahmad@mnsuam.edu.pk
Person responsible for updating data
Contact
Name of organization / entity
Muhammad Institute of Medical and Allied Sciences, Multan
Full name of responsible person
Tooba Hareem
Position
Final yeasr student of DPT
Latest degree
Medical doctor
Other areas of specialty/work
Physiotherapy
Street address
Hbl street sabsazar metro station
City
Multan
Province
Punjab
Postal code
66000
Phone
+92 312 6827130
Email
toobahareem1@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available